Wells Fargo (WFC) Projects 16.2% EPS Growth for 2026 Earnings Report
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 01 2026
0mins
Source: NASDAQ.COM
- Stock Performance: Wells Fargo (WFC) fell 1.18% to $93.20 in the latest trading session, underperforming the S&P 500's daily loss of 0.74%, indicating market caution regarding its short-term outlook.
- Monthly Growth: The stock has risen 9.26% over the past month, significantly outperforming the Finance sector's gain of 2.1% and the S&P 500's 0.79%, showcasing its relative strength in the market.
- Earnings Expectations: The company is projected to report an EPS of $1.65 on January 14, 2026, reflecting a 16.20% year-over-year increase, which indicates ongoing improvements in profitability.
- Revenue Forecast: The anticipated revenue for Q1 2026 is $21.49 billion, representing a 5.45% increase compared to the same quarter last year, further solidifying Wells Fargo's position in the financial sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WFC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WFC
Wall Street analysts forecast WFC stock price to rise
17 Analyst Rating
10 Buy
6 Hold
1 Sell
Moderate Buy
Current: 75.920
Low
74.00
Averages
98.66
High
113.00
Current: 75.920
Low
74.00
Averages
98.66
High
113.00
About WFC
Wells Fargo & Company is a financial services company. The Company provides a diversified set of banking, investment and mortgage products and services, as well as consumer and commercial finance, to individuals, businesses and institutions. The Company operates through four segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth & Investment Management. The Company provides consumer financial products and services, including checking and savings accounts, credit and debit cards, and auto, residential mortgage, and small business lending. In addition, the Company offers financial planning, private banking, investment management, and fiduciary services. It also provides financial solutions to businesses through products and services including traditional commercial loans and lines of credit, letters of credit, asset-based lending and leasing, trade financing, treasury management, and investment banking services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Banking Sector Faces Challenges Amid Rising Rates
- Industry Growth Challenges: While the banking sector has seen a 10.6% gain over the past six months, Fulton Financial's annual revenue growth of only 8.9% indicates a lag in market demand compared to peers, potentially impacting its long-term profitability.
- Declining Profitability: PennyMac Mortgage Investment Trust has experienced a 23.1% decline in annual sales over the past five years, with earnings per share decreasing more than revenue, suggesting its products struggle to compete in the market, which may weaken investor confidence.
- Soft Capital Generation: Wells Fargo's net interest income growth of 5.1% has fallen short of other banks, and its net interest margin has shrunk by 38.7 basis points over the last two years, indicating a decline in loan profitability and potential challenges in future capital generation.
- Valuation Risks: Fulton Financial and PennyMac Mortgage Investment Trust have forward P/B ratios of 1.1x and 0.7x respectively, reflecting market caution regarding their future growth prospects, which could influence investor decision-making.
See More
Morgan Stanley's Wealth Management Sees Strong Growth
- Wealth Management Growth: Over the past five years, Morgan Stanley has attracted more than $1.6 trillion in net new assets, serving over 20 million client relationships, with wealth management client assets reaching $7.4 trillion and generating $31.8 billion in annual revenue at a 29.3% pre-tax margin, showcasing its robust performance in the wealth management sector.
- Strong Investment Banking: In Q1, Morgan Stanley's investment banking revenues hit $10.7 billion, up 19% year-over-year, with advisory revenues surging 74% to $978 million, reflecting a rebound in M&A activity particularly in technology and industrial sectors, further solidifying its market position.
- Outstanding Market Performance: Morgan Stanley has outperformed Citigroup, Wells Fargo, and Bank of America in annualized total returns over the past 15 years, demonstrating its competitive edge in the financial markets, especially in the current bullish environment.
- Risk Management Strategy: The stock has steadily risen over the past year, currently approaching the key psychological level of $200, and if it can break through effectively, it will provide greater upside potential for investors, indicating its strength in a healthy equity market.
See More
Impact of New Fed Chair on Major Banks
- New Leadership: Kevin Warsh took over as the new Fed Chair on May 15, promising to change the Fed's philosophy, which could significantly impact the profitability of major banks like JPMorgan Chase and Bank of America.
- Interest Rate Policy Impact: Warsh's interest rate policy is similar to Powell's, where low inflation maintains low rates; however, if rates rise, JPMorgan's loan costs will increase, potentially reducing demand and affecting profitability.
- Balance Sheet Adjustments: Warsh opposes the Fed holding short-term Treasuries and mortgage loans, and if he begins offloading assets, it could pull liquidity from the financial system, increasing the interest banks must pay depositors, posing a short-term challenge to profitability.
- Regulatory Easing Benefits: Warsh aims to reduce regulations that have burdened banks since the 2007-2009 financial crisis, lowering compliance costs and capital requirements, which could enhance bank profitability and promote lending and shareholder returns.
See More
Analysis of Impact of New Fed Chair on Banks
- New Chair Takes Office: Kevin Warsh was sworn in as the Federal Reserve Chair on May 15, promising to change the Fed's policy philosophy, which could impact bank earnings, particularly for large banks like JPMorgan Chase.
- Balance Sheet Reduction: Warsh opposes the Fed holding assets like short-term Treasury securities and mortgage loans, and if he begins offloading these, it could pull liquidity from the financial system, increasing the interest banks must pay depositors and potentially hurting profitability.
- Regulatory Relief: Warsh aims to reduce the regulatory burdens imposed on large banks since the 2007-2009 financial crisis by slashing compliance costs and capital requirements, which could enhance banks' profitability and expand their lending capacity.
- Optimistic Profit Outlook: JPMorgan Chase's net income has reached $58 billion, and under Warsh's policies, banks may be able to lend more aggressively, leading to higher profits amid the ongoing growth of the U.S. economy.
See More
Analyst Downgrades Phreesia Rating and Price Target
- Rating Downgrade Impact: Wells Fargo analyst Stan Berenshteyn downgraded Phreesia's rating from overweight to equal weight, resulting in a 3.5% drop in the stock during a trading session where the S&P 500 rose over 1%, indicating market concerns about its future performance.
- Significant Price Target Cut: The analyst slashed Phreesia's price target from $15 to $9, nearly halving it, which reflects a pessimistic outlook on the company's future revenue growth amid increasing competition in the healthcare tech sector.
- Revenue Estimates Reduced: Due to heightened competition, the analyst lowered expectations for Phreesia's crucial subscription revenue, noting that patient intake software is more replaceable than workflow software, thereby exposing the company to greater market pressures.
- Client Base Risk: The analyst highlighted that Phreesia's strength lies in private practitioners, a segment increasingly targeted by smaller developers, which further exacerbates the company's competitive risks and could impact its market share.
See More
Phreesia Stock Drops After Analyst Downgrade
- Downgrade Impact: Analyst Stan Berenshteyn from Wells Fargo downgraded Phreesia's rating from overweight to equal weight, resulting in a 3.5% drop in its stock price despite the S&P 500 gaining over 1%, indicating market concerns about the company's outlook.
- Price Target Adjustment: The analyst lowered Phreesia's price target from $15 to $9, reflecting a decrease in subscription revenue expectations and highlighting the increasing competition the company faces in the healthcare tech sector.
- Increased Competition Risk: Berenshteyn noted that Phreesia's patient intake software is more replaceable than its workflow software, making the company vulnerable to competition from smaller developers targeting this segment.
- Client Base Challenges: The analyst pointed out that Phreesia's strength lies in private practitioners, a segment increasingly targeted by smaller developers, which could impact the company's long-term growth potential.
See More
Banking Sector Faces Challenges Amid Rising Rates
- Industry Growth Challenges: While the banking sector has seen a 10.6% gain over the past six months, Fulton Financial's annual revenue growth of only 8.9% indicates a lag in market demand compared to peers, potentially impacting its long-term profitability.
- Declining Profitability: PennyMac Mortgage Investment Trust has experienced a 23.1% decline in annual sales over the past five years, with earnings per share decreasing more than revenue, suggesting its products struggle to compete in the market, which may weaken investor confidence.
- Soft Capital Generation: Wells Fargo's net interest income growth of 5.1% has fallen short of other banks, and its net interest margin has shrunk by 38.7 basis points over the last two years, indicating a decline in loan profitability and potential challenges in future capital generation.
- Valuation Risks: Fulton Financial and PennyMac Mortgage Investment Trust have forward P/B ratios of 1.1x and 0.7x respectively, reflecting market caution regarding their future growth prospects, which could influence investor decision-making.
See More
Morgan Stanley's Wealth Management Sees Strong Growth
- Wealth Management Growth: Over the past five years, Morgan Stanley has attracted more than $1.6 trillion in net new assets, serving over 20 million client relationships, with wealth management client assets reaching $7.4 trillion and generating $31.8 billion in annual revenue at a 29.3% pre-tax margin, showcasing its robust performance in the wealth management sector.
- Strong Investment Banking: In Q1, Morgan Stanley's investment banking revenues hit $10.7 billion, up 19% year-over-year, with advisory revenues surging 74% to $978 million, reflecting a rebound in M&A activity particularly in technology and industrial sectors, further solidifying its market position.
- Outstanding Market Performance: Morgan Stanley has outperformed Citigroup, Wells Fargo, and Bank of America in annualized total returns over the past 15 years, demonstrating its competitive edge in the financial markets, especially in the current bullish environment.
- Risk Management Strategy: The stock has steadily risen over the past year, currently approaching the key psychological level of $200, and if it can break through effectively, it will provide greater upside potential for investors, indicating its strength in a healthy equity market.
See More
Impact of New Fed Chair on Major Banks
- New Leadership: Kevin Warsh took over as the new Fed Chair on May 15, promising to change the Fed's philosophy, which could significantly impact the profitability of major banks like JPMorgan Chase and Bank of America.
- Interest Rate Policy Impact: Warsh's interest rate policy is similar to Powell's, where low inflation maintains low rates; however, if rates rise, JPMorgan's loan costs will increase, potentially reducing demand and affecting profitability.
- Balance Sheet Adjustments: Warsh opposes the Fed holding short-term Treasuries and mortgage loans, and if he begins offloading assets, it could pull liquidity from the financial system, increasing the interest banks must pay depositors, posing a short-term challenge to profitability.
- Regulatory Easing Benefits: Warsh aims to reduce regulations that have burdened banks since the 2007-2009 financial crisis, lowering compliance costs and capital requirements, which could enhance bank profitability and promote lending and shareholder returns.
See More
Analysis of Impact of New Fed Chair on Banks
- New Chair Takes Office: Kevin Warsh was sworn in as the Federal Reserve Chair on May 15, promising to change the Fed's policy philosophy, which could impact bank earnings, particularly for large banks like JPMorgan Chase.
- Balance Sheet Reduction: Warsh opposes the Fed holding assets like short-term Treasury securities and mortgage loans, and if he begins offloading these, it could pull liquidity from the financial system, increasing the interest banks must pay depositors and potentially hurting profitability.
- Regulatory Relief: Warsh aims to reduce the regulatory burdens imposed on large banks since the 2007-2009 financial crisis by slashing compliance costs and capital requirements, which could enhance banks' profitability and expand their lending capacity.
- Optimistic Profit Outlook: JPMorgan Chase's net income has reached $58 billion, and under Warsh's policies, banks may be able to lend more aggressively, leading to higher profits amid the ongoing growth of the U.S. economy.
See More
Analyst Downgrades Phreesia Rating and Price Target
- Rating Downgrade Impact: Wells Fargo analyst Stan Berenshteyn downgraded Phreesia's rating from overweight to equal weight, resulting in a 3.5% drop in the stock during a trading session where the S&P 500 rose over 1%, indicating market concerns about its future performance.
- Significant Price Target Cut: The analyst slashed Phreesia's price target from $15 to $9, nearly halving it, which reflects a pessimistic outlook on the company's future revenue growth amid increasing competition in the healthcare tech sector.
- Revenue Estimates Reduced: Due to heightened competition, the analyst lowered expectations for Phreesia's crucial subscription revenue, noting that patient intake software is more replaceable than workflow software, thereby exposing the company to greater market pressures.
- Client Base Risk: The analyst highlighted that Phreesia's strength lies in private practitioners, a segment increasingly targeted by smaller developers, which further exacerbates the company's competitive risks and could impact its market share.
See More
Phreesia Stock Drops After Analyst Downgrade
- Downgrade Impact: Analyst Stan Berenshteyn from Wells Fargo downgraded Phreesia's rating from overweight to equal weight, resulting in a 3.5% drop in its stock price despite the S&P 500 gaining over 1%, indicating market concerns about the company's outlook.
- Price Target Adjustment: The analyst lowered Phreesia's price target from $15 to $9, reflecting a decrease in subscription revenue expectations and highlighting the increasing competition the company faces in the healthcare tech sector.
- Increased Competition Risk: Berenshteyn noted that Phreesia's patient intake software is more replaceable than its workflow software, making the company vulnerable to competition from smaller developers targeting this segment.
- Client Base Challenges: The analyst pointed out that Phreesia's strength lies in private practitioners, a segment increasingly targeted by smaller developers, which could impact the company's long-term growth potential.
See More
